Defense Department To Award Bioterror Testing Platform Contract By Summer
This article was originally published in The Gray Sheet
Executive Summary
The diagnostic platform targeted by the Department of Defense's bioterrorism acquisition process likely will include electrochemiluminescence (ECL) technology, according to DoD